Pathkey.AI Ltd (ASX:PKY)

Australia flag Australia · Delayed Price · Currency is AUD
0.0220
0.00 (0.00%)
Mar 24, 2026, 2:03 PM AEST
Market Cap13.36M +189.9%
Revenue (ttm)290.26K -60.3%
Net Income-1.44M
EPS-0.01
Shares Out607.08M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume400,000
Average Volume1,121,802
Open0.0230
Previous Close0.0220
Day's Range0.0220 - 0.0230
52-Week Range0.0140 - 0.0360
Beta1.08
RSI46.40
Earnings DateMay 27, 2026

About Pathkey.AI

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathke... [Read more]

Sector Healthcare
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PKY
Full Company Profile

Financial Performance

In fiscal year 2025, Pathkey.AI's revenue was 321,991, a decrease of -65.45% compared to the previous year's 932,076. Losses were -1.45 million, -53.75% less than in 2024.

Financial Statements